Inhibiting its expression significantly suppressed lung cancer cell proliferation (Fig. 5K, L), Analysis of The Cancer Genome Atlas (TCGA) database revealed that RBM45 is significantly upregulated in lung cancer (Fig. S4B). Here, RBM45 is linked to lung cancer.